Do you have the same question? Follow this Question
Jul 10, 2025 - 01:45 PM
We’ve provided several answers to questions related to Binosto (Alendronate Sodium) , see some other helpful Q&A related to this product.
Question: How is Binosto administered?
Answer: Binosto is administered by mouth. This oral route is convenient and allows for easy self-administration, promoting adherence to the treatment regimen.
Question: What is the DrugBank identifier for Binosto?
Answer: The DrugBank identifier for Binosto is DB00630. This identifier allows access to comprehensive drug data, which is valuable for healthcare providers and researchers in understanding drug interactions and properties.
Question: What is the ChEBI identifier for Binosto?
Answer: The ChEBI identifier for Binosto is 2567. This identifier is used in chemical databases to provide detailed information on chemical properties and interactions, aiding in research and clinical use.
Question: What is the MedlinePlus identifier for Binosto?
Answer: The MedlinePlus identifier for Binosto is a601011. This identifier provides easy access to consumer-friendly information about the drug, facilitating better understanding and adherence to treatment.
Question: What are the brand names for Alendronate Sodium?
Answer: The brand names for Alendronate Sodium include Fosamax and Binosto. Recognizing these brands helps consumers identify their options and ensures they receive the correct product as prescribed.
Question: What is the dosage strength of Binosto?
Answer: Binosto is available in a dosage strength of 70mg. This specific dosage is tailored to effectively manage bone density without causing excessive side effects, making it suitable for long-term treatment.
Question: What is the legal status of Binosto?
Answer: Binosto is an Rx-only medication, meaning it requires a prescription from a healthcare provider. This ensures that its use is monitored by a professional who can manage its benefits and potential risks.
Question: What is the bioavailability of Binosto?
Answer: The bioavailability of Binosto is 0.6%. This low bioavailability means that only a small portion of the drug reaches systemic circulation, which is common for oral medications and influences dosing strategies to ensure therapeutic effectiveness.
Question: What is the formula for Binosto?
Answer: The formula for Binosto is C4H13NO7P2. This chemical composition is crucial as it defines the structure and properties of the medication, ensuring its effectiveness in treating osteoporosis.
